Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: CapitalLosses who wrote (58804)	8/24/2000 5:01:34 PM
From: Oleg Sogolov	Read Replies (1) \| Respond to of 122087

Hi, I have been following this stock since last pop about a month ago. The stock hit $15 at the time and did not budge for like 2 weeks. It is a very thinly traded stock, though nowadays, just mention the word genomics or opticals and the stock takes off like crazy. It certainly looks attractive as a short, though my prior personal experience suggests there are better fish to short out there: DSLN is still not done yet, so I would short DSLN-> much better, less riskier short. BTW, still holding MZON, hoping for another 1/2 point drop before saying goodbye. I can not believe MZON got that much boost on MSFT reseller news. The news is old, no matter how you package it with EXLUSIVE RIGHTS or just PLAIN RIGHTS.